Brief: Sino Biopharmaceutical Signs Equity Investment And Strategic Cooperation Agreement
20/11/2024 01:02
Nov 20 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* SIGNING EQUITY INVESTMENT AND STRATEGIC COOPERATION
AGREEMENT
WITH LANOVA MEDICINES
* DEAL FOR LM-108 IN MAINLAND CHINA REGION
Further company coverage: 1177.HK
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit